Skip to main content

Day: April 26, 2021

CleanSpark CEO to Present at H.C. Wainwright Cryptocurrency, Blockchain, and Fintech Conference on April 27, 2021

SALT LAKE CITY, April 26, 2021 (GLOBE NEWSWIRE) — CleanSpark, Inc. (Nasdaq: CLSK) (the “Company” or “CleanSpark”), a diversified software, services, and Bitcoin mining company, today announced that CEO Zach Bradford will be presenting at the virtual H.C. Wainwright Cryptocurrency, Blockchain & FinTech Conference, Tuesday, April 27, 2021. CleanSpark’s CEO Zach Bradford will be a speaker during the Crypto Mining: Technology, Flexibility, and Sustainability Panel at 10:00 a.m. Eastern time. The panel will feature other Blockchain and Mining industry CEOs and experts. Bradford will also be available for meetings with institutional investors and analysts throughout the conference. To attend the conference, or learn more, visit: https://hcwevents.com/crypto/#toggle-id-2 Also this week, CleanSpark Executive Chairman Matthew Schultz...

Continue reading

ZIVO Bioscience Announces US Patent Office Notice of Allowance for Administration of Proprietary Algal Biomass to Support Immune Health

KEEGO HARBOR, Mich., April 26, 2021 (GLOBE NEWSWIRE) — ZIVO Bioscience, Inc. (OTCMKTS:ZIVO) a biotech/agtech R&D company engaged in the development and commercialization of nutritional/nutraceutical product candidates originally derived from proprietary algal cultures, announces today the US Patent Office has issued a Notice of Allowance for the use of the company’s proprietary algal biomass product to promote a healthy immune response for use in dairy cattle. Follow-on patent filings for other animal species and humans are in process. This new patent allowance protects a nutritionally based approach that involves the administration of the Company’s proprietary algal culture in the form of extracts, supernatants and dried biomass to support and promote a robust and healthy immune response. However, the path of discovery, validation...

Continue reading

Riber: 2020 full-year earnings positive in a difficult environment

Press release 2020 full-year earnings positive in a difficult environmentSolid revenues, with 25% sales growth for services and accessories Gross margin up 0.5 points Positive net income of €0.3m €8m of cash at end-2020Bezons, April 26, 2021 – 5:45pm – RIBER, the global leader for molecular beam epitaxy (MBE) equipment serving the semiconductor industry, is releasing its full-year earnings for 2020.(€m – at December 31) 2020 2019 ChangeRevenues 30.2 33.5 -10%MBE systems revenues 18.2 23.0 -21%Evaporators revenues 0.3 1.1 -68%Services and accessories revenues 11.7 9.4 +25%Gross margin% of revenues 9.130.1% 9.929.6% -€0.8mOperating income% of revenues 0.72.3% 0.92.7% -€0.2mNet income% of revenues 0.30.9% 1.13.4% -€0.8mCovid-19 The health crisis and the lockdown measures introduced by governments...

Continue reading

RIBER : Résultats annuels 2020 positifs dans un environnement difficile

Communiqué de presse Résultats annuels 2020 positifs dans un environnement difficileSolidité du chiffre d’affaires avec une progression des ventes de services et accessoires de 25% Progression de la marge brute de 0,5 point Résultat net positif de 0,3 M€ Trésorerie de 8 M€ à fin 2020Bezons, le 26 avril 2021 – 17h45 – RIBER, leader mondial des équipements d’épitaxie par jets moléculaires (MBE) pour l’industrie des semi-conducteurs, annonce ses résultats annuels 2020.(en M€ – au 31 décembre) 2020 2019 ÉvolutionChiffre d’affaires 30,2 33,5 –10 %CA Systèmes MBE 18,2 23,0 -21 %CA Évaporateurs 0,3 1,1 -68 %CA Services et accessoires 11,7 9,4 +25 %Marge bruteen % CA 9,130,1 % 9,929,6 % -0,8 M€Résultat opérationnelen % CA 0,72,3 % 0,92,7 % –0,2 M€Résultat neten % CA 0,30,9 % 1,13,4 % -0,8 M€Covid-19  La...

Continue reading

CREDIT AGRICOLE NORD DE FRANCE : RESULTATS AU 31 MARS 2021

 Lille, le 26 avril 2021 Résultats financiers au 31 mars 2021 du Crédit Agricole Mutuel Nord de FranceBonne tenue de l’activité et des résultats  Mars 2021 Mars 2020 Variation                                              Activité :      Encours de collecte globale 33 416 M€ 29 961 M€ +11,5%Encours de crédits 26 876 M€ 24 928 M€ +7,8%  Résultats sociaux* :                                                       Produit Net Bancaire 145 M€ 141,1 M€ +2,8%Résultat Brut d’Exploitation 50,9 M€ 52,8 M€ -3,5%Résultat Net 23,2 M€ 21,8 M€ +6,5%  Résultats consolidés IFRS :Produit Net Bancaire 156,7 M€ 148,9 M€ +5,2%Résultat Brut d’Exploitation 44,7 M€ 44,7 M€ +0%Résultat Net Part du Groupe 21,7 M€ 17,6 M€             +23,4%                      Structure financière :      Bilan consolidé 35 825 M€ 34...

Continue reading

Industrial Nanotech, Inc. CEO Stuart Burchill Stands Behind Company’s EPX-H2O and a Blowtorch

Broomfield, CO, April 26, 2021 (GLOBE NEWSWIRE) — via NewMediaWire — Industrial Nanotech, Inc. (OTC-PINK: INTK), a global leader in nanotechnology based energy saving solutions, offers a video showing their CEO/CTO, Stuart Burchill, successfully doing a dangerous demonstration of the Company’s EPX-H2O product that is resistant to chemicals, fire, and corrosion and provides best-in-class weatherproof thermal insulation for severe service environments. The blowtorch video can be found on YouTube at:  https://youtu.be/K5G3SluA7F4 EPX-H2O has been used successfully around the world in many industrial applications, with companies reporting energy savings on average of 20%-25% annually, while also protecting equipment from corrosion and chemical exposure damage. The product is sold through the Company’s brand www.syneffex.com  Details on...

Continue reading

Current Signed Customers Expected to Generate $1M Annualized Reported Revenues from Precipio’s HemeScreen POL Offering by Q4-2021

NEW HAVEN, Conn., April 26, 2021 (GLOBE NEWSWIRE) — Specialty diagnostics company Precipio, Inc. (NASDAQ: PRPO), announced that currently, the contracted annualized revenues from signed customers for its HemeScreen POL (Physician Office Laboratory) testing system exceed $750,000 and for the reasons set forth below, by Q4-2021 this cohort is expected to result in reported quarterly revenues with an annualized run rate of $1,000,000. With an additional pipeline of over 30 prospective customers nationwide, Precipio currently reaffirms its forecast that product revenues will reach approximately 50% of pathology revenue by the fourth quarter of 2021. The annualized reported revenues from the cohort of current signed customers are expected to increase to $1,000,000 by Q4-2021 because newly signed customers typically make smaller contractual...

Continue reading

Vishay Intertechnology Infrared Sensor Module Features Extended Temperature Range for Outdoor Applications

MALVERN, Pa., April 26, 2021 (GLOBE NEWSWIRE) — Vishay Intertechnology, Inc. (NYSE: VSH) today introduced a new extended temperature “E” option for its TSSP77038 infrared (IR) sensor module in the Heimdall package. Designed to meet the special requirements of outdoor applications, the Vishay Semiconductors TSSP77038ETR has been enhanced with a storage temperature range of -40 °C to +110 °C and an operating temperature range of -30 °C to +85 °C. Standard packages for IR sensor modules offer limited storage and operating temperature ranges of -25 °C to +85 °C. With the robust design of its Heimdall package, the TSSP77038ETR is able to handle a wider temperature range, making the device ideal for operation in applications exposed to direct sunlight and large temperature variations, including garage door light barrier systems, door...

Continue reading

BBS-Bioactive Bone Substitutes Plc: Submission of CE marking application for ARTEBONE® products moves to August

Stock Exchange Release April 26th, 2021 at 06.00 pm Due to delays affecting the application process, the management of BBS-Bioactive Bone Substitutes Plc (“BBS”, “Company”) has changed its estimate regarding the submission date of the ARTEBONE® products CE marking application. The company expects to submit the application during August this year. Earlier, the company had estimated that the application could be submitted during April this year. The delay is due to equipment, material and service deliveries to Oulu laboratory and Reisjärvi factory being delayed significantly due to the COVID-19 situation. Repairing a detected structural fault in Reisjärvi factory’s clean room has delayed the start of the validation process. In addition, the results from the animal testing have been delayed significantly. We expect to receive the final report...

Continue reading

BBS-Bioactive Bone Substitutes Oyj: ARTEBONE®-tuotteen CE-merkintähakemuksen jättäminen siirtyy elokuulle

Yhtiötiedote 26.4.2021, klo 18:00 BBS-Bioactive Bone Substitutes Oyj:n (“BBS”, “Yhtiö”) johto on muuttanut arviotaan Yhtiön ARTEBONE®-tuotteen CE-merkintälupahakemuksen jättämisestä hakuprosessiin liittyvien viiveiden seurauksena. Yhtiö arvioi nyt jättävänsä CE-merkintähakemuksen tämän vuoden elokuussa. Aikaisemmin arvioitiin, että hakemus saadaan jätettyä tämän vuoden huhtikuun aikana. Aikataulumuutoksen syynä on, että laite-, materiaali- ja palvelutoimitukset Reisjärven tehtaalle ja Oulun laboratorioon ovat merkittävästi viivästyneet koronan vuoksi. Reisjärven tehtaalla olevissa puhdastiloissa on ilmennyt ilmastoinnin rakennevirhe, jonka korjaaminen on viivästyttänyt ARTEBONE®-tuotteen validointiprosessien aloitusta. Lisäksi eläinkoetulosten valmistuminen on viivästynyt merkittävästi aiemmin tiedotetusta. Lopullista raporttia odotetaan...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.